MyAverix Finance
HK · Healthcare
Consun Pharmaceutical Group (1681)
Drug Manufacturers - Specialty & Generic
Consun Pharmaceutical Group (1681) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $12.18B, P/E ratio is 9.98, net margin is 31.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1681
Consun Pharmaceutical Group (1681) — FAQ
What is Consun Pharmaceutical Group's market cap?
Consun Pharmaceutical Group (1681) has a reported market cap of $12.18B (data as of 2026-05-21).
What is 1681's P/E ratio?
The price-to-earnings (P/E) ratio for Consun Pharmaceutical Group (1681) is 9.98 (data as of 2026-05-21).
Does Consun Pharmaceutical Group pay a dividend?
Dividend yield is not available in the current snapshot for Consun Pharmaceutical Group (1681). Check the MyAverix Finance app for the latest dividend data.
What sector is Consun Pharmaceutical Group in?
Consun Pharmaceutical Group (1681) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1681 listed on?
1681 is listed on HK.
What is Consun Pharmaceutical Group's net margin?
Consun Pharmaceutical Group (1681) reports a net margin of 31.6% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.